Safety and Effectiveness of Meropenem in Infants With Suspected or Complicated Intra-abdominal Infections
- Cohen-Wolkowiez, Michael
- Poindexter, Brenda
- Bidegain, Margarita
- Weitkamp, Joern Hendrik
- Schelonka, Robert L.
- Randolph, David A.
- Ward, Robert M.
- Wade, Kelly
- Valencia, Gloria
- Burchfield, David
- Arrieta, Antonio
- Mehta, Varsha
- Walsh, Michele
- Kantak, Anand
- Rasmussen, Maynard
- Sullivan, Janice E.
- Finer, Neil
- Rich, Wade
- Brozanski, Beverly S.
- Van Den Anker, John
- Blumer, Jeffrey
- Laughon, Matthew
- Watt, Kevin M.
- Kearns, Gregory L.
- Capparelli, Edmund V.
- Martz, Karen
- Berezny, Katherine
- Benjamin, Daniel K.
- Smith, P. Brian
Publication date
January 2012
DOIAbstract
Background. Intra-abdominal infections are common in young infants and lead to significant morbidity and mortality. Meropenem is a broad-spectrum antimicrobial with excellent activity against pathogens associated with intra-abdominal infections. The purpose of this study was to determine the safety and effectiveness of meropenem in young infants with suspected or complicated intra-abdominal infections
Add to ORKG